Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data
Bio Expo
Champignondagen
  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Business

WuXi Biologics CEO Dr. Chris Chen: Ready for Rapid Expansion

  • The Pharma Data
  • January 18, 2025

WuXi Biologics, delivered a keynote address at the 43rd J.P. Morgan Healthcare Conference, providing an insightful look into the company’s latest achievements, strategies, and future outlook. His presentation highlighted WuXi…

Read MoreWuXi Biologics CEO Dr. Chris Chen: Ready for Rapid Expansion
  • Press Releases

UCB Highlights a Decade of Growth and Patient-Centered Innovation Strategy

  • The Pharma Data
  • January 18, 2025

UCB is A global biopharmaceutical leader committed to improving the lives of people living with severe diseases, highlighted its decade of growth and strategic priorities at the 43rd J.P. Morgan…

Read MoreUCB Highlights a Decade of Growth and Patient-Centered Innovation Strategy
  • News

Walgreens Resources for the ‘Quad-demic’ Vaccines, Treatments, and Support

  • The Pharma Data
  • January 18, 2025

Walgreens Steps Up Amid the ‘Quad-Demic’: Vaccines, Testing, Treatments, and Support The term “tripledemic” gained traction not too long ago to describe the simultaneous surges of flu, COVID-19, and respiratory…

Read MoreWalgreens Resources for the ‘Quad-demic’ Vaccines, Treatments, and Support
  • Regulatory

Incyte and Syndax Announce FDA Approval of Niktimvo\u2122 (Axatilimab) in 9 mg and 22 mg Vials

  • The Pharma Data
  • January 18, 2025

Incyte and Syndax Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of Niktimvo™ (axatilimab-csfr) in 9 mg and 22 mg vial sizes. The companies expect the product to…

Read MoreIncyte and Syndax Announce FDA Approval of Niktimvo\u2122 (Axatilimab) in 9 mg and 22 mg Vials
  • Business

WHO Launches $1.5B Health Emergency Appeal

  • The Pharma Data
  • January 18, 2025

Unprecedented challenges such as conflict, climate change, epidemics, and displacement are converging to create a severe global health crisis, leaving 305 million people in dire need of humanitarian assistance in…

Read MoreWHO Launches $1.5B Health Emergency Appeal
  • Business

Orion Nomination Committee’s 2025 AGM Proposals

  • The Pharma Data
  • January 18, 2025

The Nomination Committee of Orion Corporation has provided its recommendations to the company’s Board of Directors regarding proposals for the 2025 Annual General Meeting (AGM). These recommendations address both the…

Read MoreOrion Nomination Committee’s 2025 AGM Proposals
  • Research

Pheno Therapeutics Receives Clinical Trial Authorization for MS Candidate PTD802

  • The Pharma Data
  • January 15, 2025

Pheno Therapeutics Receives Clinical Trial Authorization for MS Candidate PTD802 Pheno Therapeutics Limited, a leading biotechnology company focused on developing small molecule therapeutics for neurological diseases, has received Clinical Trial…

Read MorePheno Therapeutics Receives Clinical Trial Authorization for MS Candidate PTD802
  • News

Bayer’s Pharma Growth Strategy Advances as Pipeline Progresses

  • The Pharma Data
  • January 15, 2025

Bayer’s Pharma Growth Strategy Advances as Pipeline Progresses At the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG revealed significant advancements in its pharmaceutical growth strategy, announcing multiple…

Read MoreBayer’s Pharma Growth Strategy Advances as Pipeline Progresses
  • Research

First Participants Enrolled in AskBio Phase II Gene Therapy Trial for Parkinson’s Disease

  • The Pharma Data
  • January 15, 2025

First Participants Enrolled in AskBio Phase II Gene Therapy Trial for Parkinson’s Disease AskBio Inc., a leading gene therapy company and a subsidiary of Bayer AG, announced today that the…

Read MoreFirst Participants Enrolled in AskBio Phase II Gene Therapy Trial for Parkinson’s Disease
  • Press Releases

MIREVO Japan’s 1st Neuropsychological Test for Dementia Treatment Now Available

  • The Pharma Data
  • January 15, 2025

MIREVO Japan’s 1st Neuropsychological Test for Dementia Treatment Now Available Otsuka Pharmaceutical and Ai-BrainScience Inc. have announced the launch of MIREVO®, a pioneering neuropsychological testing program designed to support medical…

Read MoreMIREVO Japan’s 1st Neuropsychological Test for Dementia Treatment Now Available
  • Business

Sarclisa Secures 1st Approval in China for Relapsed/Refractory Multiple Myeloma

  • The Pharma Data
  • January 15, 2025

Sarclisa Secures 1st Approval in China for Relapsed/Refractory Multiple Myeloma The National Medical Products Administration (NMPA) of China has granted approval for Sarclisa (isatuximab), an anti-CD38 monoclonal antibody, in combination…

Read MoreSarclisa Secures 1st Approval in China for Relapsed/Refractory Multiple Myeloma
  • Regulatory

Datopotamab Deruxtecan Receives Priority Review for Advanced EGFR+ NSCLC

  • The Pharma Data
  • January 15, 2025

Datopotamab Deruxtecan Granted Priority Review by FDA for Advanced EGFR-Mutated NSCLC AstraZeneca and Daiichi Sankyo recently announced that the U.S. Food and Drug Administration (FDA) has accepted their Biologics License…

Read MoreDatopotamab Deruxtecan Receives Priority Review for Advanced EGFR+ NSCLC
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Element Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies
  • NBDF’s Pathway to Cures Backs LUNA Trial for Non-Drug Treatment of Heavy Menstrual Bleeding
  • Roseman University Unveils Roseman Bioventures, a 120,000-Square-Foot Life Sciences Incubator in Las Vegas
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.